# Clinical Cases: Transfusion Medicine

## Case 1: Acute Hemolytic Transfusion Reaction

### Patient Presentation
**Demographics:** 45-year-old female

**Chief Complaint:** Fever, back pain, and dark urine during blood transfusion

**History of Present Illness:**
The patient is receiving her second unit of packed red blood cells for symptomatic anemia following GI bleeding. Fifteen minutes into the transfusion, she develops sudden onset fever (39.2C), rigors, severe lower back pain, and chest tightness. The nurse notices her urine in the Foley bag has turned dark red.

**Past Medical History:**
- Peptic ulcer disease with acute GI bleed
- Type A Rh-positive (per hospital records)
- Prior transfusion 2 years ago without complications

**Pre-transfusion Labs:**
- Hemoglobin: 6.8 g/dL
- Blood type: A positive (documented)

### Workup and Results

**During Reaction:**
- Blood pressure: 88/52 mmHg (was 118/72)
- Heart rate: 124 bpm
- Temperature: 39.2C
- Dark red urine (hemoglobinuria)

**Immediate Investigation:**
- **Clerical check reveals error: Unit labeled B positive was issued to A positive patient**
- Direct antiglobulin test (DAT): 4+ positive
- Plasma: Pink (free hemoglobin)
- LDH: 1,850 U/L (elevated)
- Haptoglobin: <10 mg/dL (depleted)
- Bilirubin: 4.2 mg/dL (rising)
- PT/PTT: Prolonged (DIC developing)

### Clinical Image

![Hemolytic Transfusion Reaction](case_01_image.jpg)

*Comparison of normal plasma (left) with hemolyzed plasma from acute hemolytic transfusion reaction (right), showing characteristic pink discoloration from free hemoglobin release.*

### Diagnosis
**ABO-Incompatible Acute Hemolytic Transfusion Reaction**

Due to clerical error: Type B blood transfused into Type A recipient
- Anti-B antibodies in recipient immediately attacked donor B red cells
- Resulting in massive intravascular hemolysis

### Discussion
This case illustrates acute hemolytic transfusion reaction:

- **Clerical Error**: The lecture emphasizes that ABO incompatibility (clerical error) is the most common cause of acute hemolytic transfusion reactions. This underscores the importance of bedside verification.

- **ABO Antibodies**: The lecture explains that naturally occurring ABO antibodies are primarily IgM, which efficiently activate complement causing rapid intravascular hemolysis.

- **Intravascular Hemolysis Markers**: The lecture identifies elevated LDH, depleted haptoglobin, hemoglobinemia, and hemoglobinuria as markers of intravascular hemolysis.

- **DIC Risk**: The lecture notes that massive hemolysis releases tissue factor and red cell contents, triggering disseminated intravascular coagulation.

### Treatment Plan
1. **Immediate Actions:**
   - STOP the transfusion immediately
   - Keep IV line open with normal saline
   - Return blood bag and tubing to blood bank
   - Recheck patient identification and unit label

2. **Supportive Care:**
   - Aggressive IV fluid resuscitation
   - Maintain urine output >1 mL/kg/hour (preserve renal function)
   - Vasopressors if hypotension refractory to fluids

3. **Laboratory Workup:**
   - Recheck ABO/Rh typing
   - Direct antiglobulin test
   - Free hemoglobin (plasma and urine)
   - Coagulation studies (DIC panel)
   - Renal function

4. **Monitoring:**
   - ICU admission
   - Serial creatinine (acute kidney injury risk)
   - Serial coagulation studies

### Teaching Points
1. ABO incompatibility from clerical error is the most common cause of acute AHTR
2. ALWAYS stop transfusion immediately when reaction suspected
3. ABO antibodies (IgM) cause complement-mediated intravascular hemolysis
4. Hemoglobinuria indicates intravascular hemolysis
5. Goal: maintain urine output to prevent hemoglobin-induced AKI

---

## Case 2: TRALI vs TACO

### Patient Presentation
**Demographics:** 68-year-old male

**Chief Complaint:** Acute respiratory distress 2 hours after platelet transfusion

**History of Present Illness:**
The patient with acute myeloid leukemia received a platelet transfusion for thrombocytopenia. Two hours later, he developed sudden onset dyspnea, hypoxia, and bilateral crackles. He is now in respiratory distress requiring supplemental oxygen.

**Past Medical History:**
- Acute myeloid leukemia on chemotherapy
- Mild heart failure (EF 45%)
- Chronic kidney disease stage 3

**Two Possible Diagnoses Being Considered:**
- Transfusion-Related Acute Lung Injury (TRALI)
- Transfusion-Associated Circulatory Overload (TACO)

### Workup and Results

**Vital Signs:**
- Blood pressure: 165/95 mmHg
- Heart rate: 110 bpm
- Temperature: 37.1C
- SpO2: 82% on room air

**Physical Examination:**
- General: Severe respiratory distress
- Lungs: Diffuse bilateral crackles
- Cardiac: S3 gallop present
- JVP: Elevated (12 cm)
- Lower extremities: 2+ pitting edema

**Laboratory Studies:**
- BNP: 1,850 pg/mL (markedly elevated)
- Troponin: Mildly elevated

**Chest X-ray:**
- Bilateral pulmonary infiltrates
- Cardiomegaly
- Kerley B lines

### Clinical Image

![TACO vs TRALI](case_01_image.jpg)

*Chest X-ray demonstrating bilateral pulmonary edema. Key distinguishing features for TACO include cardiomegaly, elevated BNP, and hypertension, whereas TRALI typically presents with hypotension and normal BNP.*

### Diagnosis
**Transfusion-Associated Circulatory Overload (TACO)**

Distinguishing features supporting TACO over TRALI:
- Hypertension (TRALI typically hypotensive)
- Elevated BNP (>1,000 pg/mL suggests TACO)
- Pre-existing cardiac disease
- Signs of volume overload (JVP, edema, S3)

### Discussion
This case contrasts TACO and TRALI:

- **TACO Mechanism**: The lecture describes TACO as cardiogenic pulmonary edema from volume overload. Risk factors include pre-existing cardiac/renal disease and large/rapid transfusion volumes.

- **TRALI Mechanism**: The lecture explains TRALI is caused by anti-HLA or anti-neutrophil antibodies in donor plasma activating recipient neutrophils in the lung, causing capillary leak. It is non-cardiogenic pulmonary edema.

- **Key Distinguishing Features**: The lecture identifies elevated BNP and hypertension as suggesting TACO, while hypotension suggests TRALI. Both present within 6 hours with bilateral infiltrates and hypoxia.

- **TRALI Mitigation**: The lecture notes that excluding plasma from female donors who have been pregnant (higher HLA antibody prevalence) has significantly reduced TRALI incidence.

### Treatment Plan
**For TACO:**
1. **Immediate:**
   - Stop or slow transfusion
   - Upright positioning
   - Supplemental oxygen
   - Diuresis (furosemide)

2. **Supportive Care:**
   - BiPAP if needed
   - Morphine for dyspnea relief (cautiously)

3. **Prevention for Future Transfusions:**
   - Slow infusion rate
   - Diuretic pre-medication
   - Consider smaller volume transfusions

**If TRALI:**
1. Stop transfusion immediately
2. Supportive care (oxygen, mechanical ventilation if needed)
3. AVOID diuretics (non-cardiogenic)
4. Report to blood bank for donor evaluation

### Teaching Points
1. TACO: Cardiogenic edema; TRALI: Non-cardiogenic (antibody-mediated)
2. Elevated BNP and hypertension favor TACO; hypotension favors TRALI
3. TRALI caused by anti-HLA/anti-neutrophil antibodies in donor plasma
4. TACO treated with diuretics; TRALI supportive care only
5. Both present within 6 hours with bilateral infiltrates

---

## Case 3: Massive Transfusion Protocol

### Patient Presentation
**Demographics:** 32-year-old male

**Chief Complaint:** Major trauma from motor vehicle collision

**History of Present Illness:**
The patient was the unrestrained driver in a high-speed motor vehicle collision. He is brought to the trauma bay hypotensive and unresponsive. He has obvious abdominal distension and unstable pelvic fracture. Estimated blood loss is significant.

**Initial Assessment:**
- Airway: Intubated in field
- Breathing: Mechanical ventilation, bilateral breath sounds
- Circulation: BP 62/40 mmHg, HR 142 bpm, cool extremities

### Workup and Results

**Initial Labs:**
- Hemoglobin: 5.2 g/dL
- Platelets: 68,000/mcL
- INR: 2.1
- Fibrinogen: 85 mg/dL
- pH: 7.18 (acidosis)
- Lactate: 8.2 mmol/L

**FAST Exam:**
- Large amount of free fluid in abdomen

### Clinical Image

![Massive Transfusion](case_01_image.jpg)

*Diagram illustrating massive transfusion protocol with balanced 1:1:1 ratio of packed red blood cells, fresh frozen plasma, and platelets, designed to replace whole blood and prevent dilutional coagulopathy.*

### Diagnosis
**Hemorrhagic Shock Class IV with Coagulopathy Requiring Massive Transfusion**

Criteria for massive transfusion protocol activation:
- Anticipated need for >10 units pRBC in 24 hours
- Hemodynamically unstable with ongoing bleeding
- Blood loss >50% blood volume

### Discussion
This case illustrates massive transfusion principles:

- **Definition**: The lecture defines massive transfusion as 10 or more units of packed red blood cells in 24 hours, or replacement of entire blood volume.

- **1:1:1 Ratio**: The lecture describes the recommended ratio of 1:1:1 for pRBC:FFP:platelets, designed to approximate whole blood and prevent dilutional coagulopathy. The PROPPR trial supported this balanced approach.

- **Emergency Release**: The lecture explains that when blood type is unknown in emergencies, O-negative blood (universal donor for RBCs) should be given. For women of childbearing age, Rh-negative is preferred to prevent Rh sensitization.

- **Hypothermia Prevention**: The lecture notes that massive transfusion contributes to the "lethal triad" of hypothermia, acidosis, and coagulopathy. Blood warmers and active warming are essential.

### Treatment Plan
1. **Activate Massive Transfusion Protocol:**
   - 1:1:1 ratio pRBC:FFP:platelets
   - Blood bank prepares "cooler" with balanced products

2. **Initial Resuscitation:**
   - 2 units O-negative pRBC immediately (or type-specific once available)
   - Tranexamic acid 1g IV bolus (within 3 hours of injury)
   - Calcium supplementation (citrate-induced hypocalcemia)

3. **Blood Products:**
   - Continue balanced transfusion
   - Use blood warmer for all products
   - Cryoprecipitate if fibrinogen <150 mg/dL

4. **Surgical Control:**
   - Emergent laparotomy for hemorrhage control
   - Damage control surgery principles

5. **Monitoring:**
   - Serial labs every 30-60 minutes
   - Viscoelastic testing (TEG/ROTEM) if available
   - Temperature monitoring

6. **Prevent Lethal Triad:**
   - Active warming
   - Correct acidosis with resuscitation
   - Replace clotting factors

### Teaching Points
1. Massive transfusion defined as ≥10 units pRBC in 24 hours
2. Use 1:1:1 ratio (pRBC:FFP:platelets) for balanced resuscitation
3. O-negative blood for emergency when type unknown (O Rh-negative for women of childbearing age)
4. Prevent lethal triad: hypothermia, acidosis, coagulopathy
5. Tranexamic acid within 3 hours reduces mortality in trauma

---

## Image Reference

For visual reference of transfusion medicine concepts, see:
- Radiopaedia: [Transfusion reactions](https://radiopaedia.org/articles/transfusion-reactions) - Overview
- Wikipedia: [Blood transfusion](https://en.wikipedia.org/wiki/Blood_transfusion) - Components
- Radiopaedia: [TRALI](https://radiopaedia.org/articles/transfusion-related-acute-lung-injury) - Imaging

---

## Learning Points

1. **AHTR Prevention**: Clerical error is #1 cause - always verify patient ID at bedside

2. **TACO vs TRALI**: Elevated BNP and hypertension = TACO; hypotension = TRALI

3. **Massive Transfusion**: 1:1:1 ratio (pRBC:FFP:platelets) approximates whole blood

4. **Emergency Blood**: O-negative for unknown type; O Rh-negative for women of childbearing age

5. **Stop and Report**: Always stop transfusion immediately when reaction suspected